Ghent, BELGIUM, April 07, 2026 (GLOBE NEWSWIRE) — Press launch
Biotalys (Euronext: BTLS), an Agricultural Know-how (AgTech) firm creating protein-based biocontrol options for sustainable crop safety, immediately introduced it has achieved a primary analysis milestone in its partnership with Syngenta, a world chief in agricultural innovation, to develop a novel bioinsecticide towards key insect pests. Preliminary laboratory exams demonstrated promising in vitro outcomes with novel bioactive substances developed utilizing Biotalys’ distinctive AGROBODY™ know-how towards the insect molecular goal.
Carlo Boutton, interim CEO of Biotalys, stated: “Biotalys is dedicated to developing regenerative crop protection solutions that combine the efficacy of conventional products with the sustainability benefits of biologicals. Working with industry leaders like Syngenta enables us to accelerate the path from research to the field. This first milestone is an important step in validating the potential of our technology platform in insect control, and we look forward to continuing our work with our partner to deliver novel, differentiated modes of action that can be seamlessly integrated into growers’ integrated pest management programs to expand the range of effective tools available to them.”
As insect resistance continues to rise alongside tightening regulatory and environmental constraints, growers are more and more looking for new options that stay efficient over time whereas decreasing environmental affect. Biotalys’ protein-based biocontrols supply a brand new class of crop safety energetic substances that help growers in managing resistant insect populations whereas providing a focused, secure and sustainable strategy to crop safety.
The groups from each corporations will proceed to the subsequent analysis part, testing energetic substances on residing organisms (in vivo). Syngenta can pay Biotalys a primary milestone, reflecting continued progress within the collaboration whereas not materially impacting Biotalys’ present money runway.
More Read
About Biotalys
Biotalys is an Agricultural Know-how (AgTech) firm creating precision biocontrol options primarily based on proteins for the safety of crops in each the pre- and post-harvest markets. The corporate gives novel options that bridge the efficacy and scale of chemistry with the environmental benefits of organic options. Based mostly on its novel AGROBODY™ know-how platform, Biotalys is creating a powerful and numerous pipeline of efficient product candidates with a positive security profile that purpose to handle key crop pests and illnesses throughout the entire worth chain, from soil to plate. Biotalys was based in 2013 as a spin-off from the VIB (Flanders Institute for Biotechnology) and is listed on Euronext Brussels. The corporate is predicated within the biotech cluster in Ghent, Belgium. Extra info will be discovered on www.biotalys.com.
More Read
For additional info, please contact:
Necessary Discover
Biotalys, its enterprise, prospects and monetary place stay uncovered and topic to dangers and uncertainties. An outline of and reference to those dangers and uncertainties will be discovered within the annual report on the consolidated annual accounts printed on the corporate’s web site.
Biotalys doesn’t have enough working capital to cowl the working capital wants for a interval of at the least 12 months as of the date hereof and solely has a money runway till the tip of Might 2026. The corporate would require further funds past this era so as to meet its capital and expenditure wants and guarantee its going concern even when the meant restructuring of the corporate could be accomplished as introduced within the firm’s press launch of 9 February 2026. The corporate is in dialogue with present and new buyers and continues to judge financing choices it being famous that, on the date hereof, no concrete financing choices or proposals are obtained by the corporate. Such financing may not be out there when wanted or, if out there, may not be out there on commercially beneficial phrases.
This announcement incorporates statements that are “forward-looking statements” or may very well be thought of as such. These forward-looking statements will be recognized by means of forward-looking terminology, together with the phrases ‘aim’, ‘imagine’, ‘estimate’, ‘anticipate’, ‘anticipate’, ‘intend’, “have the potential”, ‘might’, ‘will’, ‘plan’, ‘proceed’, ‘ongoing’, ‘doable’, ‘predict’, ‘plans’, ‘goal’, ‘search’, ‘would’ or ‘ought to’, and include statements made by the corporate relating to the meant outcomes of its technique. By their nature, forward-looking statements contain dangers and uncertainties and readers are warned that none of those forward-looking statements provides any assure of future efficiency. Biotalys’ precise outcomes might differ materially from these predicted by the forward-looking statements. Biotalys makes no endeavor in any respect to publish updates or changes to those forward-looking statements, until required to take action by legislation.
